HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bruno Frediani Selected Research

Precision Medicine

2/2022Neutrophil Extracellular Traps in ANCA-Associated Vasculitis and Interstitial Lung Disease: A Scoping Review.
12/2021Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bruno Frediani Research Topics

Disease

29Uveitis
05/2024 - 01/2012
23Rheumatoid Arthritis
03/2024 - 06/2004
13Osteoporosis
01/2023 - 07/2006
12Inflammation (Inflammations)
10/2022 - 05/2012
11Fever (Fevers)
11/2023 - 07/2012
9Necrosis
08/2023 - 05/2013
9COVID-19
07/2023 - 01/2020
8Pain (Aches)
06/2023 - 05/2015
8Vasculitis (Vasculitides)
04/2023 - 01/2017
7Axial Spondyloarthritis
03/2024 - 07/2018
7autosomal dominant familial Periodic fever
01/2021 - 11/2012
6Psoriatic Arthritis
03/2024 - 01/2013
6Interstitial Lung Diseases (Interstitial Lung Disease)
11/2023 - 03/2021
5Retinal Vasculitis
05/2024 - 01/2017
5Neoplasms (Cancer)
12/2023 - 06/2006
5Infections
12/2023 - 01/2017
5Arthritis (Polyarthritis)
11/2023 - 06/2011
5Myositis (Idiopathic Inflammatory Myopathies)
10/2023 - 01/2021
5Scleritis (Episcleritis)
08/2022 - 10/2017
5Bone Resorption
01/2022 - 01/2009
5Amyloidosis
01/2020 - 09/2013
4Synovitis
01/2024 - 11/2019
4Panuveitis
08/2023 - 01/2019
4Anterior Uveitis
08/2023 - 11/2016
4Rheumatic Diseases (Rheumatism)
04/2023 - 10/2016
4Macular Edema
03/2021 - 01/2017
4Knee Osteoarthritis
01/2021 - 08/2018
4Alkaptonuria
07/2017 - 09/2013
3Herpes Zoster
12/2023 - 07/2021
3Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2023 - 01/2020
3Autoimmune Diseases (Autoimmune Disease)
05/2023 - 01/2014
3Sarcoidosis (Schaumann Disease)
05/2023 - 01/2021
3Microscopic Polyangiitis
04/2023 - 02/2022
3Serositis
01/2023 - 11/2012
3Giant Cell Arteritis (Horton Disease)
01/2023 - 01/2020
3Adult-Onset Still's Disease
12/2022 - 01/2020
3Abdominal Pain (Pain, Abdominal)
10/2022 - 11/2012
3Overweight
05/2022 - 01/2021
3Complex Regional Pain Syndromes
01/2022 - 08/2018
3Edema (Dropsy)
04/2021 - 03/2020
3Behcet Syndrome (Behcet's Syndrome)
01/2020 - 07/2015
3Ankylosing Spondylitis
07/2018 - 05/2015
3Mevalonate Kinase Deficiency
06/2018 - 01/2013
3Cryopyrin-Associated Periodic Syndromes
06/2018 - 01/2013
2Spondylarthritis (Spinal Arthritis)
12/2023 - 01/2020
2Lymphadenopathy
11/2023 - 01/2020
2Pneumonia (Pneumonitis)
11/2023 - 01/2021
2Hypertension (High Blood Pressure)
08/2023 - 04/2021
2Intermediate Uveitis (Chronic Cyclitis)
08/2023 - 02/2019
2Posterior Uveitis
08/2023 - 02/2019

Drug/Important Bio-Agent (IBA)

14Adalimumab (Humira)FDA Link
08/2023 - 11/2013
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024 - 11/2012
12Antirheumatic Agents (DMARD)IBA
12/2023 - 01/2017
12Adrenal Cortex Hormones (Corticosteroids)IBA
06/2023 - 05/2012
11Biomarkers (Surrogate Marker)IBA
07/2023 - 06/2004
10GlucocorticoidsIBA
01/2024 - 07/2006
10Diphosphonates (Bisphosphonates)IBA
01/2023 - 10/2004
10InterleukinsIBA
01/2022 - 05/2013
9Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2020 - 07/2012
8Tumor Necrosis Factor InhibitorsIBA
01/2024 - 05/2013
8SteroidsIBA
01/2023 - 01/2017
7Biosimilar PharmaceuticalsIBA
01/2024 - 10/2016
7tocilizumab (atlizumab)FDA Link
01/2023 - 09/2013
7CytokinesIBA
01/2022 - 09/2013
7Interleukin-1 (Interleukin 1)IBA
01/2021 - 01/2017
7Infliximab (Remicade)FDA Link
02/2019 - 11/2013
6Clodronic Acid (Clodronate)IBA
03/2020 - 01/2009
5Janus Kinase InhibitorsIBA
03/2024 - 09/2020
5Fluorescein (Funduscein)FDA LinkGeneric
03/2024 - 01/2017
5golimumabFDA Link
03/2024 - 01/2019
5Ferritins (Ferritin)IBA
11/2023 - 01/2021
5Immunosuppressive Agents (Immunosuppressants)IBA
08/2023 - 07/2012
56- amino- 1- hydroxyhexane- 1,1- diphosphonateIBA
10/2022 - 11/2008
5Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2013
5InflammasomesIBA
01/2021 - 01/2013
4AntibodiesIBA
10/2023 - 01/2017
4Monoclonal AntibodiesIBA
08/2023 - 07/2017
4ColchicineFDA LinkGeneric
01/2023 - 07/2012
4EnzymesIBA
01/2023 - 12/2013
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2023 - 03/2021
4C-Reactive ProteinIBA
05/2022 - 07/2018
4canakinumabFDA Link
01/2020 - 04/2015
4Etanercept (Enbrel)FDA Link
01/2020 - 11/2013
4Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2019 - 01/2013
3HLA Antigens (Human Leukocyte Antigens)IBA
05/2024 - 01/2020
3Immunoglobulin G (IgG)IBA
07/2023 - 01/2022
3Rituximab (Mabthera)FDA Link
03/2023 - 01/2021
3baricitinibIBA
01/2023 - 09/2020
3Methotrexate (Mexate)FDA LinkGeneric
01/2023 - 01/2013
3Certolizumab PegolFDA Link
01/2021 - 11/2017
3Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2021 - 09/2013
2HLA-B51 AntigenIBA
05/2024 - 01/2020
2Janus KinasesIBA
03/2024 - 07/2021
2upadacitinibIBA
01/2024 - 10/2023
2Rheumatoid FactorIBA
08/2023 - 01/2021
2Anti-Citrullinated Protein AntibodiesIBA
08/2023 - 01/2021
2Vitamin DFDA LinkGeneric
07/2023 - 06/2011

Therapy/Procedure

26Therapeutics
01/2024 - 06/2004
8Biological Therapy
12/2023 - 01/2018
3Injections
12/2023 - 01/2020